OU,
I believe that anything is possible with our FDA, but I believe that in Europe they want the vaccine and will approve it. Many countries around the world will follow suit, and American's will travel to get it.
Fortunately, if this is the case, sales elsewhere will both support the share price and pay for whatever the FDA demands. I believe that a blind man could see the benefits of the vaccine, but sometimes the FDA can be deaf, dumb, and blind.
I do suspect that Biden's loss of his son due to GBM might have some influence on the FDA, especially if Europe acts to approve before the FDA takes any action. I frankly don't know if what Beau Biden had was what's currently defined as GBM, but as I see it, unless the data says otherwise, DCVax-L should be approved for many, if not all, forms of brain cancer.
I think we all need to remember that it's not NWBO's fault that many patients in the trial had diseases that today are not considered GBM, they were up to a matter of months ago, and at the time the trial began, IDH wasn't known at all as I understand it, now the FDA wants things broken down to the point that you're right, they could say there were not sufficient patients of any type. What should matter is all the people who're still alive, or lived much longer than anticipated, but they could be blind to such evidence.
Gary
Market Data 
Markets 
AI
